This public procurement record has 3 releases in its history.

Award

08 Aug 2023 at 17:07

Award

15 Jul 2022 at 10:03

Award

01 Mar 2022 at 12:24

Summary of the contracting process

The NHS England has awarded a contract for the NHS Framework for the North of England, Branded Medicine. The procurement process was conducted using an open procedure. The contract value is £431,836,170 GBP, and the contract period is from 1st March 2022 to 29th February 2024. The tender had a deadline on 20th October 2021. The procurement is in the pharmaceutical products category and is suitable for small and medium-sized enterprises (SMEs). The contract was awarded to multiple suppliers including Thornton and Ross Ltd, Janssen-Cilag Ltd, Biogen, and others.

This procurement opportunity for the NHS Framework for the North of England, Branded Medicine presents a significant chance for businesses to provide goods and services to NHS England. Companies operating in the pharmaceutical products industry would be well-suited to compete for this contract. The framework contract covers various regions in the UK, providing opportunities for suppliers across different areas including the East Midlands, London, North East, and more. With a focus on branded medicines, this tender offers a platform for growth and collaboration for both large-scale suppliers and SMEs.

How relevant is this notice?

Notice Title

NHS Framework for the North of England, Branded Medicine

Notice Description

Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£431,836,170 £100M-£1B
Lots Value
Not specified
Awards Value
£238,913,892 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
8 Aug 20233 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
7 Feb 20224 years ago
Contract Period
1 Mar 2022 - 29 Feb 2024 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
31
Supplier Names

Thornton and Ross Ltd

Janssen-Cilag Ltd

Biogen

Merck Serono Limited

Celltrion Healthcare United Kingdom Limited

Bristol Myers Squibb

AstraZeneca

UL Global Pharma

GlaxoSmithKline UK Limited

Roche Products Ltd

Bayer Plc

Merck Sharpe & Dohme (UK) Limited

Pfizer Ltd

Accord-UK Ltd

Novo Nordisk

Sandoz Ltd

Napp Pharmaceuticals Ltd

Eli Lilly & Company Ltd

Ipsen

Amgen Ltd

Aventis Pharma ltd

UCB Pharma Ltd

Teva UK Limited

Zentiva Pharma UK Ltd

CST Pharma Limited

Takeda UK Ltd

Mylan

Gilead Sciences Limited

Organon Pharmaceuticals UK Ltd

Gedeon Richter UK Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...